Alvotech (ALVO) Depreciation & Amortization (CF) (2021 - 2026)

Alvotech (ALVO) posted Depreciation & Amortization (CF) of $10.3 million for Q1 2026, little changed on a QoQ basis from $10.3 million in Q3 2025, and up 24.56% year-over-year from $8.3 million in Q1 2025.

Alvotech (ALVO) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Alvotech's Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $10.3 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 24.56% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.5 million (down 46.92% YoY) and the FY2023 annual result came in at $24.2 million, up 18.62% from the prior year.
  • Depreciation & Amortization (CF) was $10.3 million for Q1 2026 at Alvotech, roughly flat from $10.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $31.3 million in Q4 2024 and bottomed at $4.7 million in Q1 2022.
  • A 5-year average of $8.9 million and a median of $7.4 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) increased 3.2% — and 2024, when it jumped 365.44%.
  • Alvotech's Depreciation & Amortization (CF) stood at $5.3 million in 2022, then climbed by 26.29% to $6.7 million in 2023, then soared by 365.44% to $31.3 million in 2024, then sank by 67.15% to $10.3 million in 2025, then rose by 0.05% to $10.3 million in 2026.
  • Business Quant data shows ALVO's Depreciation & Amortization (CF) at $10.3 million in Q1 2026, $10.3 million in Q3 2025, and $8.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn 10.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.29 Mn
Mar 31, 2026 10.29 Mn
Sep 30, 2025 10.28 Mn
Sep 30, 2025 10.28 Mn
Jun 30, 2025 8.90 Mn
Jun 30, 2025 8.90 Mn
Mar 31, 2025 8.26 Mn
Mar 31, 2025 8.26 Mn
Dec 31, 2024 31.30 Mn
Dec 31, 2024 31.30 Mn
Sep 30, 2024 8.40 Mn
Sep 30, 2024 8.40 Mn
Jun 30, 2024 7.56 Mn
Jun 30, 2024 7.56 Mn
Mar 31, 2024 7.19 Mn
Mar 31, 2024 7.19 Mn
Dec 31, 2023 6.73 Mn
Dec 31, 2023 6.73 Mn
Jun 30, 2023 6.09 Mn
Jun 30, 2023 6.09 Mn